AccueilSTAT | Reporting from the frontiers of health and medicineSTAT+: GSK to buy RAPT Therapeutics, maker of food allergy treatment, in $2.2B dealSTAT+: GSK to buy RAPT Therapeutics, maker of food allergy treatment, in $2.2B dealSTAT | Reporting from the frontiers of health and medicine • Publié le 20 janvier 2026🇬🇧 → 🇫🇷 PDF Extrait J'aime Je n'aime pas Suivre Source GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies. Espace publicitaire · 300×250